Risk | Very High | Very High |
Rating | 2.0 | 3.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.04 | 1.93 |
NAV | ₹19.02 | ₹40.36 |
Fund Started | 06 Oct 2020 | 12 Nov 2018 |
Fund Size | ₹156.68 Cr | ₹3138.46 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 1 month. |
1 Year | 33.82% | 49.05% |
3 Year | 14.99% | 21.11% |
5 Year | - | 30.89% |
Equity | 99.95% | 96.74% |
Cash | -0.01% | 3.26% |
Top 10 Holdings |
|
|
Name | Bhavesh Jain | Jay Kothari |
Start Date | 01 Oct 2021 | 16 Mar 2018 |
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. |
Launch Date | 06 Oct 2020 | 12 Nov 2018 |